Business

Sacramento, CA, Nov. 06, 2026 (GLOBE NEWSWIRE) — SPACCircle Acquisition Corp. (Nasdaq: SCQCU) (the “Company”) announced today that, commencing November 10, 2026, holders of the units sold in the Company’s initial public

WOBURN, Mass., Nov. 06, 2026 (GLOBE NEWSWIRE) — Biofrontera Inc. (NASDAQ: BFRI) (“Biofrontera” or the “Company”), a U.S.-based biopharmaceutical company engaging in the development, manufacturing, and commercialization of pharmaceutical products for the

WESTLAKE VILLAGE, Calif., Nov. 06, 2026 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced the grant of an aggregate

MINNETONKA, Minn., Nov. 06, 2026 (GLOBE NEWSWIRE) — On November 6, 2026, the Board of Directors of Table Trac Inc. (OTCQX: TBTC) declared a quarterly cash dividend of $0.02 per share on

NEW YORK, Nov. 06, 2026 (GLOBE NEWSWIRE) — IN8bio, Inc. (the “Company”) (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies and T cell engagers for cancer and

PALO ALTO, Calif., Nov. 06, 2026 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, today announced that on

MALVERN, Pa., Nov. 06, 2026 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA Bio”) (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation

Conference Call Scheduled for Friday, November 13, 2026 at 9:00 AM ET PORTLAND, Maine, Nov. 06, 2026 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company

WALTHAM, Mass., Nov. 06, 2026 (GLOBE NEWSWIRE) — Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company committed to developing next-generation therapies that elevate the standard in immunology

ATLANTA, Nov. 06, 2026 (GLOBE NEWSWIRE) — Mueller Water Products, Inc. (NYSE: MWA), a leading manufacturer and marketer of products and solutions used in the transmission, distribution and measurement of water in